Search results
Dec 26, 2023 · The Novo Nordisk Foundation is the controlling shareholder of Danish drugmaker Novo Nordisk, currently Europe’s most valuable company thanks to soaring sales of weight loss and diabetes drugs...
The Novo Nordisk Foundation wishes to make significant contributions to the development and strengthening of the Danish research ecosystems, within research aimed at solving major challenges in health and the sustainability of society and the planet.
We are an enterprise foundation with a controlling interest in the Novo Group’s two large publicly listed companies, Novo Nordisk A/S and Novozymes A/S (Novonesis). Our fully owned subsidiary, Novo Holdings A/S, manages the ownership of these two companies and the Foundation’s other assets.
COPENHAGEN – SAN FRANCISCO – SEATTLE (March 14, 2022) – Today, the Novo Nordisk Foundation, Open Philanthropy, and the Bill & Melinda Gates Foundation announced an initial commitment of up to $90 million of coordinated funding toward Pandemic Antiviral Discovery (PAD), a new initiative to catalyze discovery and early development of ...
Novo Nordisk Foundation | 82,418 followers on LinkedIn. Benefitting People and Society | Our vision is to contribute significantly to research and development that improves the lives of...
Mar 6, 2024 · Established in Denmark in 1924, the Novo Nordisk Foundation is an enterprise foundation with philanthropic objectives. The vision of the Foundation is to improve people's health and the...
Sep 21, 2022 · COPENHAGEN, Denmark, Sept. 21, 2022 /PRNewswire/ -- The Novo Nordisk Foundation has awarded a grant of US$ 200 million ( DKK 1.5 billion) to establish the first full-scale quantum computer...
